-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Aura Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2024.
- Aura Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$23.2M, a 13.4% decline year-over-year.
- Aura Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$93.1M, a 19.6% decline year-over-year.
- Aura Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$85M, a 41% decline from 2022.
- Aura Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$60.3M, a 71.1% decline from 2021.
- Aura Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$35.3M, a 58.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)